Cefuroxime (2Nd Gen) Injectable (Iv, Im) Suppliers & Bulk Manufacturers
Available Forms: Injectable (IV, IM)
Available Strengths: 750 mg, 1.5 g, 3 g
Reference Brands: Ceftin, Zinacef(US & EU)
Category:
Antibiotics
Cefuroxime injectable binds to bacterial penicillin-binding proteins, inhibiting cell wall synthesis and causing bacterial lysis. It is effective against severe respiratory, urinary, and skin infections. Benefits include rapid, reliable bacterial eradication, broad-spectrum activity, good tissue penetration, and suitability for inpatient use, providing effective treatment for serious bacterial infections.
Cefuroxime (2nd Gen) Injectable (IV, IM) is available in Injectable (IV, IM)
and strengths such as 750 mg, 1.5 g, 3 g.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Cefuroxime (2nd Gen) Injectable (IV, IM) is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Cefuroxime (2nd Gen) Injectable (IV, IM) can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Cefuroxime injectable, a 2nd generation cephalosporin, is approved in the EU and US for severe bacterial infections. In the EU, brands like Zinacef are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality. In the US, FDA approval relies on extensive clinical data, with generic options available. Both regions require detailed dossiers, including clinical trial results, manufacturing standards, and pharmacovigilance plans for approval and continuous safety monitoring. Due to its critical use, strict regulations on storage, labeling, and administration are enforced. For regulatory support, compliance, and registration, visit PharmaTradz. We facilitate seamless market access for cefuroxime injections adhering to European and US standards.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing